Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2000 | 03-2000 | 12-1999 | 09-1999 | 06-1999 | |
| Sales | 1,970 | 0 | 8,460 | 2,980 | 2,140 |
| Cost of Goods | 1,300 | 0 | 6,640 | 4,440 | 2,860 |
| Gross Profit | 670 | 0 | 1,820 | -1,460 | -720 |
| Operating Expenses | 5,880 | 0 | 330 | 0 | 0 |
| Operating Income | -5,210 | 0 | 1,490 | -1,460 | -720 |
| Interest Expense | 10 | 0 | 0 | 0 | 0 |
| Other Income | -7,520 | -1,450 | -2,210 | -1,780 | -1,860 |
| Pre-tax Income | -12,740 | -1,450 | -720 | -3,240 | -2,580 |
| Income Tax | 0 | 0 | -1,200 | 0 | 0 |
| Net Income Continuous | -12,740 | -1,450 | 480 | -3,240 | -2,580 |
| Net Income | $-12,740 | $-1,450 | $-720 | $-2,040 | $-2,580 |
| EBITDA(a) | $-5,210 | $0 | $1,490 | $-1,460 | $-720 |